Tempest Granted Fast Track Designation from the U.S. Food and Drug Administration for ...
Detailed price information for Tempest Therapeutics Inc (TPST-Q) from The Globe and Mail including charting and trades.
Taiwan News5 天
Serplulimab Approved in the EU for First-Line Treatment of Extensive-Stage Small Cell Lung ...
Serplulimab is the world's first anti-PD-1 monoclonal antibody (mAb) approved for first-line treatment of ES-SCLC Serplulimab is the first and only anti-PD-1 mAb approved in the European Union (EU) ...
来自MSN6 天
PFE's Colorectal Cancer Drug Meets Other Dual Primary Goal of PFS
Pfizer PFE announced positive top-line results from the progression-free survival (PFS) analysis of a late-stage study of its ...
조선일보6 天
Celltrion's Vegzelma becomes Europe's top prescribed anticancer drug in two years
Celltrions Vegzelma becomes Europes top prescribed anticancer drug in two years Celltrions cancer treatment Vegzelma achieves impressive market dominance in Europe within two years ...
Outlook Therapeutics® Participates in Virtual Investor “What This Means” Segment
Dr. Jennifer Kissner, SVP Clinical Development, discusses the 12-week safety and efficacy results for NORSE EIGHT clinical trial Watch the “What This Means” segment here ISELIN, N.J., Feb. 04, 2025 ...